Ensemble said April 5 that the milestone happened exactly one year after the implant was introduced to the market.
“Our early experience suggests the implant presents an attractive choice for surgeons to offer patients and is becoming an accepted treatment alternative,” Ensemble CEO and co-founder William Ogilvie said. “We are extremely pleased with the progress of our controlled market rollout and very happy that our select group of trained surgeons are integrating the Ensemble [carpometacarpal implant] into their practices.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
